S Biomedics Co (XKRX:304360) COGS-to-Revenue : 0.52 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co COGS-to-Revenue?

S Biomedics Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ₩1,364 Mil. Its Revenue for the three months ended in Mar. 2024 was ₩2,607 Mil.

S Biomedics Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.52.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. S Biomedics Co's Gross Margin % for the three months ended in Mar. 2024 was 47.67%.

S Biomedics Co COGS-to-Revenue Historical Data

The historical data trend for S Biomedics Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co COGS-to-Revenue Chart

S Biomedics Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.86

0.81

0.76

0.51

0.50

S Biomedics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.55	0.43	0.54	0.51	0.52

S Biomedics Co COGS-to-Revenue Calculation

S Biomedics Co's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6001.618	/	12112.652
	=	0.50

S Biomedics Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1363.912	/	2606.555
	=	0.52

S Biomedics Co (XKRX:304360) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

S Biomedics Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1363.912 / 2606.555
	=	47.67 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

S Biomedics Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of S Biomedics Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

S Biomedics Co (XKRX:304360) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797

Website

https://www.sbiomedics.com

S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines